Search Results

Patient-Reported Outcome Data From an Early Rheumatoid Arthritis Trial

• Authors : S. Pazmino; René Westhovens; Kristien Van der Elst ...

Subjects: Male; medicine.medical_specialty; Time Factors

Record details

Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data

• Authors : Kimme L. Hyrich; Andrew Judge; Lene Dreyer

Subjects: Male; Epidemiology; medicine.medical_treatment

• Source: Hawley, S, Ali, M S, Cordtz, R, Dreyer, L, Edwards, C J, Arden, N K, Cooper, C, Judge, A, Hyrich, K & Prieto-Alhambra, D 2019, ' Impact of TNF inhibitor therapy on joint

Record details

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure

• Authors : BSRBR-RA Contributors Group; Silva-Fernández, Lucía; De Cock, Diederik ...

Subjects: Male; Time Factors; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Record details

Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)

• Authors : T. Kaegi; Scqm physicians; Hendrik Schulze-Koops ...

Subjects: Adult; Glucocorticoids/therapeutic use; Male

• Source: Clinical Rheumatology, Vol. 36, No 1 (2017) pp. 59-66

Record details

Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry

• Authors : College of Medicine; Dept. of Internal Medicine; Dong-Jin Park

Subjects: Arthritis; Rheumatoid/blood; Rheumatoid/drug therapy

Record details

Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

• Authors : Helena Canhão; Katerina Chatzidionysiou; Ellen-Margrethe Hauge ...

Subjects: Male; medicine.medical_specialty; Time Factors

• Source: Rheumatology, 55(2), 230-6. Oxford University PressWalker, U A, Jaeger, V K, Chatzidionysiou, K, Hetland, M L, Hauge, E-M, Pavelka, K, Nordström, D C, Canhão, H, Tomšič, M, van Vollenhoven,

Record details

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival

• Authors : Björn Svensson; Sofia Ajeganova; Ingiäld Hafström ...

Subjects: Male; Prednisolone/administration & dosage; medicine.medical_specialty

• Source: BMJ Open

Record details

Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice

• Authors : Marie Godfrin-Valnet; Daniel Wendling; Hubert Marotte ...

Subjects: Male; rheumatoid arthritis; [SDV]Life Sciences [q-bio]

• Source: RheumatologyRheumatology, Oxford University Press (OUP), 2014, 53 (1), pp.76-84. ⟨10.1093/rheumatology/ket301⟩

Record details

74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis

• Authors : Delabaye, Isabelle; De Keyser, Filip; Houssiau, Frédéric ...

Subjects: Male; Antirheumatic Agents -- adverse effects -- therapeutic use; Placebo-controlled study

• Source: Arthritis Research and Therapy, Vol. 12, no. 3, p. R121 (2010)Arthritis research & therapy, 12 (3ARTHRITIS RESEARCH &

Record details

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity.

• Authors : Vander Cruyssen, Bert; Durez, Patrick; Westhovens, Rene ...

Subjects: Antibodies; Monoclonal - administration & dosage; adverse effects

• Source: Arthritis Research & Therapy, Vol. 12, no. 3, p. R77 (2010)

Record details